In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds.
about
Imaging Approaches in Functional Assessment of Implantable Myogenic Biomaterials and Engineered Muscle TissueChanging Paradigms in Cranio-Facial Regeneration: Current and New Strategies for the Activation of Endogenous Stem CellsImaging challenges in biomaterials and tissue engineering.Biomaterial technology for tissue engineering applications.Microencapsulation of cytarabine using poly(ethylene glycol)-poly(epsilon-caprolactone) diblock copolymers as surfactant agents.Gelatin carriers for drug and cell delivery in tissue engineeringGelatin microspheres crosslinked with genipin for local delivery of growth factors.Nanofibrous architecture of silk fibroin scaffolds prepared with a mild self-assembly process.COMP-angiopoietin1 potentiates the effects of bone morphogenic protein-2 on ischemic necrosis of the femoral head in rats.Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect modelBiodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2Trehalose maintains bioactivity and promotes sustained release of BMP-2 from lyophilized CDHA scaffolds for enhanced osteogenesis in vitro and in vivoDelivery of plasmid DNA encoding bone morphogenetic protein-2 with a biodegradable branched polycationic polymer in a critical-size rat cranial defect model.Targeted delivery of nanoparticles to ischemic muscle for imaging and therapeutic angiogenesis.Gelatin methacrylate microspheres for controlled growth factor releaseComposite scaffold of poly(vinyl alcohol) and interfacial polyelectrolyte complexation fibers for controlled biomolecule delivery.Controlled protein delivery in the generation of microvascular networks.Founder's award to Antonios G. Mikos, Ph.D., 2011 Society for Biomaterials annual meeting and exposition, Orlando, Florida, April 13-16, 2011: Bones to biomaterials and back again--20 years of taking cues from nature to engineer synthetic polymer scExtended and sequential delivery of protein from injectable thermoresponsive hydrogelsRecent advances in bone tissue engineering scaffolds.Gelatin device for the delivery of growth factors involved in endochondral ossification.Osteochondral tissue regeneration using a bilayered composite hydrogel with modulating dual growth factor release kinetics in a rabbit model.Controlled delivery of VEGF via modulation of alginate microparticle ionic crosslinking.2007 AIChE Alpha Chi Sigma Award: From Material to Tissue: Biomaterial Development, Scaffold Fabrication, and Tissue Engineering.Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients.Polymer-based microparticles in tissue engineering and regenerative medicine.Delivery approaches for angiogenic growth factors in the treatment of ischemic conditions.Therapeutic strategies based on polymeric microparticles.25th anniversary article: Dynamic interfaces for responsive encapsulation systems.Sustained delivery of biomolecules from gelatin carriers for applications in bone regeneration.Drug delivery from gelatin-based systems.Strategies to Stimulate Mobilization and Homing of Endogenous Stem and Progenitor Cells for Bone Tissue Repair.Effects of surface area to volume ratio of PLGA scaffolds with different architectures on scaffold degradation characteristics and drug release kinetics.Preparation and functional evaluation of cell aggregates incorporating gelatin microspheres with different degradabilities.Antibiotic-releasing porous polymethylmethacrylate/gelatin/antibiotic constructs for craniofacial tissue engineering.Composite Scaffolds of Interfacial Polyelectrolyte Fibers for Temporally Controlled Release of Biomolecules.Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model.Bone regeneration by lactoferrin released from a gelatin hydrogel.Bone morphogenetic protein-2 release from composite hydrogels of oligo(poly(ethylene glycol) fumarate) and gelatin.Enhanced angiogenic efficacy through controlled and sustained delivery of FGF-2 and G-CSF from fibrin hydrogels containing ionic-albumin microspheres.
P2860
Q26766438-7F409B51-FD0A-48BD-87BD-D47FD7016138Q26768579-BE3E7755-FD83-4A32-86AA-3F605C3AE8C0Q30431707-F44D0C02-3556-4A7B-A57D-CA1FFA47B862Q30489070-3D185785-D99C-4DD0-8A33-2925BDBD6FACQ33514058-04621E4A-A1D7-4026-AB1D-AA03CC3EA53EQ34079544-47A4B08B-A289-4F5F-88A8-94799937206FQ34282125-73FBA189-F937-46AE-96CB-50942381724FQ34354283-1DE7BEAD-0C51-4184-B721-885DE14B02C6Q34362253-72446743-84A2-4C78-AF12-F1D3360047DBQ34457622-42F3FFCB-3C5A-41B3-BC33-BEDB3C072E69Q34480036-665CAADD-7CB5-415B-89CE-720D9E7A82F9Q34566292-BFF868CA-A800-4855-964D-9A3A59F07688Q34600483-0EF648DC-B8DA-45CE-BE4F-6D06AE7230B2Q34776009-A33BE701-D00A-4DE1-99DB-6064A40DBB58Q34944475-013E99B5-954B-4E52-A1BB-F0B6BAEBD0B7Q35042390-642A9B95-33F9-4287-B190-878D6B610195Q35162409-4D1F071E-2B6B-4844-B670-7BDE7AE54565Q35168811-E0EA5BC7-7FDC-4743-A8E8-532A0D3A44E6Q35696724-5088A54E-48D3-443D-8837-B20B53B131FCQ36252678-C758EE39-2F63-4776-BB92-81CF54DF39ADQ36336015-477A278B-27CB-4658-970E-C21BDB6372ABQ36867889-6C7D30A1-74A1-4E2E-A141-2411E1222DBBQ37182599-F49D00BD-D97F-421F-B3AD-148A2844B7C4Q37345739-0AA5245A-D259-4A6F-BA09-4F5C6ECC964FQ37579215-DC961159-ECED-4DD8-9B89-21106B7497C7Q37876388-8803FE69-465D-402D-A65E-CA044DD9E28DQ37885356-F9B3839C-74D8-4AE3-B4BB-95318A4DD412Q38016146-2A1604E1-D405-420C-933C-8503AEF392D2Q38133778-6186504E-F9CF-4287-8F81-16CC58197219Q38261963-3A1D7C14-CDA7-414B-9AC6-F1F905B81047Q38460704-AC4C6BB0-98C8-4659-BC62-F763B897537BQ38530142-46DC43FF-8C67-4767-B3C4-90C950E01B77Q38919399-F667A80C-107C-4A85-B373-E6EA98781469Q39375761-5234DC17-369A-4FA8-8DFC-96D9D77205D6Q41831605-E507AB87-AC9E-4C11-98FA-941E683F9F45Q42145295-D80A2B84-143D-4544-8212-1CE9104CBF93Q42240098-C8D5D20A-6CC9-40F8-90C9-3D06F5665EC7Q42824161-6CF18A55-6814-400D-9998-7E73953F381AQ44450910-502F4939-9DE7-476F-9336-A9866D89E1E7Q44673173-06582821-4C13-415A-B356-8180C16D1195
P2860
In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
In vitro and in vivo release o ...... egradable composite scaffolds.
@en
In vitro and in vivo release o ...... egradable composite scaffolds.
@nl
type
label
In vitro and in vivo release o ...... egradable composite scaffolds.
@en
In vitro and in vivo release o ...... egradable composite scaffolds.
@nl
prefLabel
In vitro and in vivo release o ...... egradable composite scaffolds.
@en
In vitro and in vivo release o ...... egradable composite scaffolds.
@nl
P2093
P1476
In vitro and in vivo release o ...... degradable composite scaffolds
@en
P2093
Antonios G Mikos
Hiroki Ueda
Yasuhiko Tabata
P2860
P304
P356
10.1007/S11095-008-9685-1
P577
2008-07-29T00:00:00Z